BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

Trans Medicare Ltd01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

Trans Medicare Ltd01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
02-Jul-2018	BC	Trading Members of the Exchange are hereby informed that the 210 companies (given in Annexure I) that have remained suspended for more than 6 months would be delisted from the platform of the Exchang	04-Jul-2018
23-May-2018	BC	Audited Results This is to inform you that a meeting of Board of Directors will be held on 30th May,2018. The Board of Directors at the meeting held on 30.05.2018 has approved inter-alia th	30-May-2018
30-May-2018	BC	The Board of Directors at the meeting held on 30.05.2018 has approved inter-alia the Audited Financial Results for the Year Ended 31st March,2018 and appointment of Independent Director.	30-May-2018
09-Feb-2018	BC	Quarterly Results This is to inform you that a meeting of the Board of Directors will be held on 14th Febrauary,2018, to transact the following business: 1) To take on record the unaudited	14-Feb-2018
08-Dec-2017	BC	Quarterly Results This is to Inform that a meeting of Board Of Directors will be held on 14th December,2017 to consider Unaudited Financial Results for the Quarter Ended 30th September,2017 Sub	14-Dec-2017

No Rights has been declared by Trans Medicare Ltd

Book Closure

Record Date	Split Date	Purpose
04-Jul-2018	-	Trading Members of the Exchange are hereby informed that the 210 companies (given in Annexure I) that have remained suspended for more than 6 months would be delisted from the platform of the Exchang
30-May-2018	-	Audited Results This is to inform you that a meeting of Board of Directors will be held on 30th May,2018. The Board of Directors at the meeting held on 30.05.2018 has approved inter-alia th
30-May-2018	-	The Board of Directors at the meeting held on 30.05.2018 has approved inter-alia the Audited Financial Results for the Year Ended 31st March,2018 and appointment of Independent Director.
14-Feb-2018	-	Quarterly Results This is to inform you that a meeting of the Board of Directors will be held on 14th Febrauary,2018, to transact the following business: 1) To take on record the unaudited
14-Dec-2017	-	Quarterly Results This is to Inform that a meeting of Board Of Directors will be held on 14th December,2017 to consider Unaudited Financial Results for the Quarter Ended 30th September,2017 Sub

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,625.70(+15.10/0.94%)	1,625.70	+15.10	73,403.11	119.86	31.55	3.56
Ipca Laboratories Ltd ₹1,284.40(-8.90/-0.69%)	1,284.40	-8.90	32,811.57	83.88	59.59	5.29
J B Chemicals & Pharmaceuticals Ltd ₹1,804.50(+1.90/0.11%)	1,804.50	+1.90	27,975.41	72.90	55.26	10.43
Sanofi India Ltd ₹8,311.05(-62.40/-0.75%)	8,311.05	-62.40	19,284.06	50.35	32.62	18.97
IOL Chemicals & Pharmaceuticals Ltd ₹383.60(+0.05/0.01%)	383.60	+0.05	2,251.65	-2.87	13.03	1.41

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Dec 17	Sep 17	Jun 17	Mar 17	Dec 16
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	0.12	0.01	0.01	0.01	0.04	0.01
PBIDT	-0.12	-0.01	-0.01	-0.01	-0.04	-0.01
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.12	-0.01	-0.01	-0.01	-0.04	-0.01
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.12	-0.01	-0.01	-0.01	-0.04	-0.01
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.12	-0.01	-0.01	-0.01	-0.04	-0.01

EPS (Unit Curr.)	-0.22	-0.03	-0.03	-0.01	-0.08	-0.03
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	-0.22	-0.03	-0.03	-0.01	-0.08	-0.03
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-0.89	-0.10	-0.10	-0.05	-0.34	-0.10
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.16	5.16	5.16	5.16	5.16	5.16
Reserve & Surplus	0.00	0.00	0.00	-10.85	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	3838800.00	3838800.00	3838800.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	74.41	74.41	74.41

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	1319950.00	1319950.00	1319950.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	100.00	100.00	100.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	25.59	25.59	25.59

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13	Mar 12
SOURCES OF FUNDS :
Share Capital	5.16	5.16	5.16	5.16	5.16	5.16
Reserves Total	-10.85	-10.74	-23.51	-21.29	-21.12	-20.72
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-5.69	-5.58	-18.35	-16.13	-15.96	-15.56
Secured Loans	8.89	8.81	13.27	13.29	13.29	13.29
Unsecured Loans	0.00	0.00	8.35	8.17	8.00	7.99
Total Debt	8.89	8.81	21.62	21.46	21.29	21.28
Total Liabilities	3.20	3.23	3.27	5.33	5.33	5.72
APPLICATION OF FUNDS :
Gross Block	0.26	0.28	1.42	2.97	2.97	2.97
Less : Accumulated Depreciation	0.00	0.00	1.10	1.65	1.65	1.65
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.26	0.28	0.32	1.32	1.32	1.32
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.01	0.01	0.01	0.33	0.33	0.33
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.95	2.95	2.95	2.95	2.95	2.95
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	0.00	0.00	0.00	0.00
Cash and Bank	0.01	0.01	0.01	0.01	0.03	0.07
Loans and Advances	0.03	0.02	0.02	0.00	0.00	0.00
Total Current Assets	0.03	0.02	0.02	0.02	0.03	0.07
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.05	0.04	0.03	0.01	0.01	0.07
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.05	0.04	0.03	0.01	0.01	0.07
Net Current Assets	-0.01	-0.02	-0.01	0.00	0.02	0.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	3.21	3.22	3.26	4.60	4.62	4.60
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash and Cash Equivalents at Beginning of the year	0.01	0.01	0.01	0.03	0.07
Net Cash from Operating Activities	-0.08	-0.10	-0.16	-0.17	-0.06
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.00	0.02
Net Cash Used In Financing Activities	0.08	0.10	0.16	0.16	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.00	0.00	-0.01	-0.01	-0.04
Cash And Cash Equivalents At End Of The Year	0.01	0.01	0.01	0.02	0.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

25.59%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

74.41%

**Promoter pledged shareholding 25.59%

About New Heaven Chemicals & Industries Ltd

New Heaven Chemicals & Industries Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 4.13 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.12 crores for the quarter ended December 2018. The company management includes , Ramesh Haridass,Urvashi Ramesh,Rajath Patankar (New Heaven Chemicals & Industries Ltd) among others.

Chairman

Registered office

H No 3-179/Nr Plot No 179,Guttalabegampet-S1 Phase II,Hyderabad,Telangana,500081

FAX :91-40-49021225

Background

Incorporation Year1989

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0